Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
Donovan McGrowder, Fabian Miller, Kurt Vaz, et al.
Brain Sciences (2021) Vol. 11, Iss. 2, pp. 215-215
Open Access | Times Cited: 105

Showing 26-50 of 105 citing articles:

A mini review of transforming dementia care in China with data-driven insights: overcoming diagnostic and time-delayed barriers
Pan Lu, Xiaolu Lin, Xiaofeng Liu, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Neuroinflammatory fluid biomarkers in patients with Alzheimer’s disease: a systematic literature review
Michael T. Heneka, Serge Gauthier, Sagar Anil Chandekar, et al.
Molecular Psychiatry (2025)
Open Access
Electrochemical biosensors for early detection of Alzheimer’s disease
Sanoeva Matlyuba Jakhonkulovna, Gulnoz Bahodirova Kamolovna, Muzaffar Zokirov, et al.
Clinica Chimica Acta (2025), pp. 120278-120278
Closed Access
A multiscale model to explain the spatiotemporal progression of amyloid beta and tau pathology in Alzheimer's disease
Chunrui Xu, Enze Xu, Yang Xiao, et al.
International Journal of Biological Macromolecules (2025), pp. 142887-142887
Open Access
Single-cell and spatial RNA sequencing identify perturbators of microglial functions with aging
Yifei Dong, Rajiv W. Jain, Brian M. Lozinski, et al.
Nature Aging (2022) Vol. 2, Iss. 6, pp. 508-525
Closed Access | Times Cited: 21
Low Intensity Electromagnetic Fields Act via Voltage-Gated Calcium Channel (VGCC) Activation to Cause Very Early Onset Alzheimer’s Disease: 18 Distinct Types of Evidence
Martin L. Pall
Current Alzheimer Research (2022) Vol. 19, Iss. 2, pp. 119-132
Open Access | Times Cited: 20
Correlation of serum complement factor 5a level with inflammatory response and cognitive function in patients with Alzheimer’s disease of different severity
Zhilian Li, Huifang Wu, Yi Luo, et al.
BMC Neurology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Biomarkers in Parkinson’s disease: A state of the art review
Kyla Y. Yamashita, Sweta Bhoopatiraju, Bret Silverglate, et al.
Biomarkers in Neuropsychiatry (2023) Vol. 9, pp. 100074-100074
Open Access | Times Cited: 12
Brain-Derived Exosomal Proteins as Effective Biomarkers for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Ka Young Kim, Ki Young Shin, Keun‐A Chang
Biomolecules (2021) Vol. 11, Iss. 7, pp. 980-980
Open Access | Times Cited: 25
Beyond CSF and Neuroimaging Assessment: Evaluating Plasma miR-145-5p as a Potential Biomarker for Mild Cognitive Impairment and Alzheimer’s Disease
Qing‐Feng Wen, Mandy Melissa Jane Wittens, Sebastiaan Engelborghs, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 5, pp. 1042-1054
Open Access | Times Cited: 3
Serum NFL and tau, but not serum UCHL-1 and GFAP or CSF SNAP-25, NPTX2, or sTREM2, correlate with delirium in a 3-year retrospective analysis
Johannes Heinrich Alexander Piel, Leon Bargemann, Frank Leypoldt, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 3
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Fardin Nabizadeh, Homa Seyedmirzaei, Shaghayegh Karami
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Demystifying the Role of Neuroinflammatory Mediators as Biomarkers for Diagnosis, Prognosis, and Treatment of Alzheimer’s Disease: A Review
Rohit Doke, Ganesh Lamkhade, Kuldeep Vinchurkar, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 10, pp. 2987-3003
Open Access | Times Cited: 3
An Overview of the Genes and Biomarkers in Alzheimer’s Disease
Hari Krishnan Krishnamurthy, Vasanth Jayaraman, Karthik Krishna, et al.
Ageing Research Reviews (2024), pp. 102599-102599
Open Access | Times Cited: 3
Classification of Alzheimer's disease using robust TabNet neural networks on genetic data
Yu Jin, Zhe Ren, Wenjie Wang, et al.
Mathematical Biosciences & Engineering (2023) Vol. 20, Iss. 5, pp. 8358-8374
Open Access | Times Cited: 8
Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
Joke Temmerman, Sebastiaan Engelborghs, Maria Bjerke, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
COVID-19 and Alzheimer's Disease: Neuroinflammation, Oxidative Stress, Ferroptosis, and Mechanisms Involved
Alicia B. Pomilio, Arturo A. Vitale, Alberto Lazarowski
Current Medicinal Chemistry (2022) Vol. 30, Iss. 35, pp. 3993-4031
Closed Access | Times Cited: 11
Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease
Yanan Xu, Hailun Jiang, Bin Zhu, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 8, pp. 2060-2073
Open Access | Times Cited: 6
Vitreous Humor Biomarkers Reflect Pathological Changes in the Brain for Alzheimer’s Disease and Chronic Traumatic Encephalopathy
Viha Vig, Itika Garg, Fatima Tuz‐Zahra, et al.
Journal of Alzheimer s Disease (2023) Vol. 93, Iss. 3, pp. 1181-1193
Open Access | Times Cited: 6
PPARɑ Ligand Caudatin Improves Cognitive Functions and Mitigates Alzheimer’s Disease Defects By Inducing Autophagy in Mice Models
Senthilkumar Krishnamoorthi, Ashok Iyaswamy, Sravan Gopalkrishnashetty Sreenivasmurthy, et al.
Journal of Neuroimmune Pharmacology (2023) Vol. 18, Iss. 3, pp. 509-528
Closed Access | Times Cited: 6
The Critical Role of Biomarkers for Drug Development Targeting the Biology of Aging
Meriel Owen, Nandita Bose, Laura Nisenbaum, et al.
The Journal of Prevention of Alzheimer s Disease (2023)
Open Access | Times Cited: 6
Synapsin 1 Ameliorates Cognitive Impairment and Neuroinflammation in Rats with Alzheimer’s Disease: An Experimental and Bioinformatics Study
Wei Ma, Kui Lu, Huamin Liang, et al.
Current Alzheimer Research (2023) Vol. 20, Iss. 9, pp. 648-659
Closed Access | Times Cited: 6
Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders
Luisa Agnello, Bruna Lo Sasso, Matteo Vidali, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3139-3139
Open Access | Times Cited: 10
Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease
Drew A. Gillett, Rebecca L. Wallings, Oihane Uriarte Huarte, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Zinc Modulation of Neuronal Calcium Sensor Proteins: Three Modes of Interaction with Different Structural Outcomes
Viktoriia E. Baksheeva, Philipp O. Tsvetkov, Arthur O. Zalevsky, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 956-956
Open Access | Times Cited: 8

Scroll to top